Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice
DOI: 10.32364/2618-8430-2020-3-4-276-281
М.S. Selikhova, P.A. Soltys, L.S. Kalacheva
Volgograd State Medical University, Volgograd, Russian Federation
The prevalence of iron-deficiency anemia (IDA) is steadily increasing. IDA is more common in women of reproductive age, pregnant women, and adolescent girls thus accounting for the importance of this issue in obstetrics and gynecology. Abnormal uterine bleeding (AUB) is one of the most common causes of IDA both in the puberty and reproductive period which requires hemostasis as well as addressing iron deficiency. A high rate of IDA was also reported in women with pelvic inflammatory diseases; this should considered when managing this large group of gynecological patients. The treatment for anemia or latent iron deficiency is performed for a long time, therefore, the selection of a medication is particularly important. Peroral Tardyferon® containing 80 mg of iron meets all modern-day requirements for anti-anemic drugs and is recommended for anemia resulting from AUB both in women of reproductive age and adolescent girls. Case studies illustrate high efficacy and good tolerability of this medication.
Keywords: iron-deficiency anemia, pregnancy, abnormal uterine bleeding in puberty, heavy menstrual bleeding, genital inflammation, high efficacy, compliance.
For citation: Selikhova М.S., Soltys P.A., Kalacheva L.S. Prevention and treatment for iron-deficiency anemia in obstetrical gynecological practice. Russian Journal of Woman and Child Health. 2020;3(4):276–281. DOI: 10.32364/2618-8430-2020-3-4-276-281.
2. Nadey E.V., Nechaeva G.I. Iron deficiency. Risk groups in general clinical practice. Lechaschii vrach. 2014;7:26–31 (in Russ.).
3. Gromova O.A., Rebrov V.G. Iron as a vital nutrient. Effective pharmacotherapy. Obstetrics, gynecology. 2012;2:46–52 (in Russ.).
4. Kovalchuk L.A., Tarkhanova A.E., Tarkhanov A.A. The role of imbalance of macro- and microelements in the pathogenesis of iron deficiency anemia in pregnant women. Medical Bulletin of Bashkortostan. 2009;2:49–51 (in Russ.).
5. Konovodova E.N., Burlev V.A. Effectiveness of Ferro-Folgamma using in pregnant and postpartum women with iron deficiency anemia. RMJ. 2003;16:899–901 (in Russ.).
6. Tikhomirov A.L., Sarsaniya S.I., Nochevkin E.V. Treatment, diagnosis and adequate prevention of iron deficiency states in the practice of an obstetrician/gynecologist. Obstetrics and gynecology. 2015;4:69–74 (in Russ.).
7. Andreeva E.N., Sheremetyeva E.V. Menstrual bleeding: diagnosis and treatment. Obstetrics and gynecology. 2019;5:186–193 (in Russ.). DOI: 10.18565/aig.2019.5.186-192.
8. Tyutyunik L.V., Balushkina A.A., Dokueva R.S. Prevention and treatment of iron-deficiency anemia during pregnancy. RMJ. Obstetrics and Gynecology. 2013;1:22–25 (in Russ.).
9. Tayupova I.M. Physiological and biochemical aspects of iron deficiency in pregnant women. Eurasian Union of Scientists (ESU). 2016;30:77–79 (in Russ.).
10. Khamadyanov U.R., Tayupova I.M., Khamadyanov A.U. Latent iron deficiency during pregnancy. Gynecology, Obstetrics and Perinatology. 2009;8(4):69–74 (in Russ.).
11. World Health Organization. Prevention and management of severe anaemia in pregnancy. Report of a Technical Working Group. Geneva: WHO; 2003.
12. Radzinsky V.E., Solovyova A.V., Kuznetsova O.A., Smirnova T.V. Pregravid preparation: proven benefits. Essential micronutrients in multivitamin complexes. Doctor.Ru. 2020;19(6):30–35 (in Russ.). DOI: 10.31550/1727-2378-2020-19-6-30-35.
13. Pregravid preparation. Clinical Protocol of the Interdisciplinary Association of Reproductive Medicine Professionals. M.: StatusPraesens; 2020 (in Russ.).
14. Federal clinical guidelines for the diagnosis and treatment of iron deficiency anemia. 2015 (in Russ.).
15. Torshin I.Yu., Gromova O.A., Tetrashvili N.K. et al. Metric analysis of comorbidity ratios between miscarriage, endometriosis, menstrual irregularities and micronutrient supply in screening women of reproductive age. Obstetrics and gynecology. 2019;5:156–168 (in Russ.). DOI: 10.18565/aig.2019.5.156-168.
16. Kuznetsova I.V. Teenage girl as a patient. Endocrine gynecology of physiological puberty: the optimal minimum of correction. M.: StatusPraesens; 2014 (in Russ.).
17. Von Wolff M., Stute P. Gynecological endocrinology and reproductive medicine. (Translated from German) M.: Medpress-inform; 2018 (in Russ.).
18. Gynecology. National leadership. M.: GEOTAR-Media; 2009 (in Russ.).
19. Tikhomirov A.L., Sarsaniya S.I. Rational therapy and modern principles of diagnosis of iron deficiency states in obstetric practice. Farmateka. 2009;1:32–39 (in Russ.).
20. National Collaborating Centre for Women s fnd Children s Health. Heavy menstrual bleeding clinical guideline 44. London: RCOG Press for NICE; 2007.
21. Prilepskaya V.N., Bebneva T.N. The effectiveness of the immunomodulator Galavit in the treatment of inflammatory diseases of the pelvic organs. RMJ. 2013;1:31–38 (in Russ.).
22. Prilepskaya V.N. Recurrent pelvic inflammatory disease: causes, effects and consequences. Effective pharmacotherapy. Obstetrics and Gynecology. 2015;3:52–54 (in Russ.).
23. Novikova V.A., Augleva F.R., Sorochenko A.A. et al. Specificity of the ovarian reserve in women with chronic salpingoophoritis. Kuban Scientific Medical Bulletin. 2018;25(6):119–126 (in Russ.). DOI: 10.25207/1608-6228-2018-25-6-119-126.
24. Thakral S., Thakral N.K., Majumdar D.K. Eudragit: a technology evaluation. Expert Opin Drug Deliv. 2013;10(1):131–149. DOI: 10.1517/17425247.2013.736962.
25. Bertumier D., Dupinet P., Tranois F.Composition with prolonged release of active substance, method of its obtaining and application. Patent № 2414211. (Electronic resource). URL: https://patents.google.com/patent/RU2414211C2/ru (access date: 20.10.2020) (in Russ.).
26. Тardiferon. State register of medicines. (Electronic resource).URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=996b7a39-8d8b-40ee-ae48-f059986a3e16andt= (access date: 20.10.2020) (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
